Antibodies and Vaccines as Drugs for COVID-19

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies｜Institute of Cellular and Organismic Biology, Academia Sinica

NCI's Research on COVID-19, Vaccines, and Antibodies - NCI

COVID-19 vaccine development: milestones, lessons and prospects

A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies, Journal of Biomedical Science

Frontiers Potential Therapeutic Targets and Vaccine Development for SARS-CoV-2/COVID-19 Pandemic Management: A Review on the Recent Update

Complexities in COVID-19 Monoclonal Antibody Manufacturing

Immunotherapy drugs show 'clear hierarchy' of poor COVID-19 vaccine response

Therapeutic vaccine for chronic diseases after the COVID-19 Era

Prior treatment with cancer drug likely renders COVID-19 vaccine ineffective, study finds, News Center

Antibodies and Vaccines as Drugs for COVID-19

9 Things You Need To Know About Molnupiravir, a New COVID-19 Pill > News > Yale Medicine

Vaccines Approved and Under Development Against COVID-19

New coronavirus variants made monoclonal antibody drugs ineffective